Angiogenin (108-122) (TFA)

发表于由

Angiogenin (108-122) (TFA); 纯度: 98.70%

Angiogenin (108-122) TFA 是一种血管生成素肽。

Angiogenin (108-122) (TFA)amp;;

Angiogenin (108-122) (TFA) Chemical Structure

规格 价格 是否有货 数量
1 mg ￥1300 In-stock
5 mg ￥5200 In-stock
10 mg ￥8100 In-stock
50 mg ; 询价 ;
100 mg ; 询价 ;

* Please select Quantity before adding items.

Angiogenin (108-122) (TFA) 相关产品

bull;相关化合物库:

  • Bioactive Compound Library Plus
  • Anti-Cancer Compound Library
  • Anti-Cardiovascular Disease Compound Library
  • Peptide Library

生物活性

Angiogenin (108-122) TFA is an angiogenin peptide.

体外研究
(In Vitro)

Angiogenin (108-122) effects on the ribonucleolytic activity of angiogenin using tRNA as substrate with 39% inhibition[1]. Angiogenin (108-122) acts as a therapeutic agent for the prophylaxis and/or treatment of cancer, an infectious disease, a fibrotic disease, an inflammatory disease, a neurodegenerative disease, an autoimmune disease, or a heart and vascular disease[2].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.
分子量

1895.00

Formula

C80H126F3N25O25
Sequence

Glu-Asn-Gly-Leu-Pro-Val-His-Leu-Asp-Gln-Ser-Ile-Phe-Arg-Arg
Sequence Shortening

ENGLPVHLDQSIFRR
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

Sealed storage, away from moisture

Powder -80deg;C 2 years
-20deg;C 1 year

*In solvent : -80deg;C, 6 months; -20deg;C, 1 month (sealed storage, away from moisture)
溶解性数据
In Vitro:;

H2O : ≥ 50 mg/mL (26.39 mM)

* “≥” means soluble, but saturation unknown.

配制储备液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 0.5277 mL 2.6385 mL 5.2770 mL
5 mM 0.1055 mL 0.5277 mL 1.0554 mL
10 mM 0.0528 mL 0.2639 mL 0.5277 mL

*

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。
储备液的保存方式和期限：-80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)。-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。
参考文献

  • [1]. Rybak SM, et al. C-terminal angiogenin peptides inhibit the biological and enzymatic activities of angiogenin. Biochem Biophys Res Commun. 1989 Jul 14;162(1):535-43.

    [2]. Dorian Bevec, et al. Therapeutic uses of angiogenin 108-122 and gluten exorphin a5. WO2009043455A2.